Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Raloxifene therapy inhibits osteoclastogenesis during the alveolar healing process in rats

Texto completo
Autor(es):
Luvizuto, Eloa R. [1] ; Dias, Sheila S. M. D. [1] ; Okamoto, Tetuo [2] ; Dornelles, Rita C. M. [3] ; Okamoto, Roberta [2]
Número total de Autores: 5
Afiliação do(s) autor(es):
[1] UNESP Univ Estadual Paulista, Aracatuba Dent Sch, Dept Surg & Integrated Clin, Jaboticabal - Brazil
[2] Univ Sagrado Coracao USC Bauru, Dept Res & Post Grad, Bauru, SP - Brazil
[3] UNESP Univ Estadual Paulista, Aracatuba Dent Sch, Dept Basic Sci, Jaboticabal - Brazil
Número total de Afiliações: 3
Tipo de documento: Artigo Científico
Fonte: ARCHIVES OF ORAL BIOLOGY; v. 56, n. 10, p. 984-990, OCT 2011.
Citações Web of Science: 17
Resumo

Objective: To investigate the expression of OPG, RANKL and TRAP during alveolar healing process (7, 14, 21, 28 and 42 postoperative days) in ovariectomized rats treated with raloxifene or with oestrogen replacement therapy, using immunohistochemistry reaction approach. Materials and methods: Wistar female rats (10 weeks age) were submitted to ovariectomy surgery (OVX) or sham surgery. The female rats were divided in four groups: (1) sham; (2) OVX/O (ovariectomy and oil); (3) OVX/E2 (ovariectomy and oestrogen replacement); (4) OVX/RLX (ovariectomy and raloxifene therapy). Results: It was observed high amount of OPG immunolabelling with predominance at 14 and 21 postoperative days on sham and OVX/RLX groups, respectively. At 7 postoperative days, there was no difference between the groups for TRAP protein. Otherwise, to the other periods, it was observed greater expression of TRAP and RANKL protein on OVX/O group compared to sham, OVX/E2 and OVX/RLX groups. It was also observed a discrete TRAP immunolabelling at 28 and 42 postoperative days on OVX/RLX group. Conclusions: Oestrogen deficiency induces osteoclastogenesis in the alveolar healing process. Quantitative changes in the osteoclastic activity could be prevented through the raloxifene therapy. (C) 2011 Elsevier Ltd. All rights reserved. (AU)

Processo FAPESP: 05/51367-5 - Interferência do estrógeno no metabolismo ósseo durante o processo de reparo alveolar: estudo imunoistoquímico e histomorfométrico em ratas
Beneficiário:Eloá Rodrigues Luvizuto
Modalidade de apoio: Bolsas no Brasil - Programa Capacitação - Treinamento Técnico
Processo FAPESP: 04/07562-5 - Interferência do estrógeno no metabolismo ósseo durante o processo de reparo alveolar: estudo imunoistoquímico e histomorfométrico em ratas
Beneficiário:Tetuo Okamoto
Modalidade de apoio: Auxílio à Pesquisa - Regular